首页 › 期刊 › 医学 › Basic & Clinical Pharmacology & Toxicology
Basic & Clinical Pharmacology & Toxicology
出版商:Wiley (Blackwell Publishing) · ISSN:1742-7835, 1742-7843, 0901-9928, 1600-0773 · 国家/地区:GB · 类型:journal · 创刊:1945 · 官网:https://onlinelibrary.wiley.com/journal/17427843
研究主题:Pharmacogenetics and Drug Metabolism · Pharmaceutical studies and practices · Drug Transport and Resistance Mechanisms · Pharmaceutical Practices and Patient Outcomes · Pharmacological Effects and Toxicity Studies
核心指标
- 影响因子(JCR 2025):3.600
- JCR 分区:Q2(PHARMACOLOGY & PHARMACY)
- 中科院分区(2025):医学 4区;小类:TOXICOLOGY 毒理学 3区
- 新锐分区(2026):医学 3区
- SJR:0.978(Q1)
- h-index:113
- i10 指数:2062
- 近两年篇均被引:2.73
- 载文量 4202 · 总被引 92889
逐年趋势
- 近年影响因子:2021 3.69 → 2022 3.1 → 2023 2.7 → 2024 3.3 → 2025 3.6
- 近年 SJR:2021 0.745(Q2) → 2022 0.681(Q2) → 2023 0.744(Q2) → 2024 0.822(Q2) → 2025 0.978(Q1)
投稿参考
- 版面费(APC)约 $4650 USD(以期刊官网为准)
- 提供 LaTeX 投稿模板(USG.cls)
同学科期刊推荐
- CA-A CANCER JOURNAL FOR CLINICIANS — IF 685.2 · JCR Q1 · 中科院1区(Top)
- The Lancet — IF 109.0 · JCR Q1 · 中科院1区(Top)
- Nature Reviews Clinical Oncology — IF 94.6 · JCR Q1 · 中科院1区(Top)
- Nature Reviews Drug Discovery — IF 91.2 · JCR Q1 · 中科院1区(Top)
- Kidney International Supplements — IF 89.6 · JCR Q1 · 中科院2区
- New England Journal of Medicine — IF 84.5 · JCR Q1 · 中科院1区(Top)
- Signal Transduction and Targeted Therapy — IF 81.2 · JCR Q1 · 中科院1区(Top)
- Annals of Oncology — IF 80.4 · JCR Q1 · 中科院1区(Top)
常见问题
《Basic & Clinical Pharmacology & Toxicology》的影响因子是多少?
根据 JCR 2025 年数据,《Basic & Clinical Pharmacology & Toxicology》的最新影响因子(IF)为 3.600。
《Basic & Clinical Pharmacology & Toxicology》是几区期刊?
《Basic & Clinical Pharmacology & Toxicology》中科院分区(2025年版)为医学4区,JCR 分区为 Q2。
《Basic & Clinical Pharmacology & Toxicology》的版面费(APC)是多少?
根据 OpenAlex 收录的价目,《Basic & Clinical Pharmacology & Toxicology》的文章处理费(APC)约为 $4650 美元。实际费用与豁免政策请以期刊官网为准。
本刊近期代表论文
- Assessing Condition-Specific Adverse Event Profiles of Modafinil for Labelled and Off-Label Uses: A Systematic Review and Meta-Analysis (2026 · 被引 77)
- Gentiopicroside Attenuated Dopaminergic Neurodegeneration via Inhibiting Neuroinflammatory Responses and Ferroptosis in Experimental Models of Parkinson's Disease (2025 · 被引 7)
- Bruceine A Inhibits Cell Proliferation by Targeting the USP13/PARP1 Signalling Pathway in Multiple Myeloma (2025 · 被引 1)
- Comparison of ciprofol (HSK3486) versus propofol for the induction of deep sedation during gastroscopy and colonoscopy procedures: A multi‐centre, non‐inferiority, randomized, controlled phase 3 clinical trial (2022 · 被引 201)
- Delineation of the GPR15 receptor‐mediated Gα protein signalling profile in recombinant mammalian cells (2022 · 被引 13)
- Prognostic value of liver and kidney function parameters and their correlation with the ratio of urine‐to‐plasma paraquat in patients with paraquat poisoning (2021 · 被引 25)